DATAS: The Dual Chamber & Atrial Tachyarrhythmias Adverse Events Study (DATAS)
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Listed as NCT00157820, this NA trial focuses on Defibrillators, Implantable and Ventricular Fibrillation and remains completed. Sponsored by Medtronic Cardiac Rhythm and Heart Failure, it has been updated 13 times since 2000, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
13 versions recorded-
Aug 2025 — Present [monthly]
Completed NA
-
Jul 2025 — Aug 2025 [monthly]
Completed NA
-
Sep 2024 — Jul 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2024 — Jul 2024 [monthly]
Completed NA
▶ Show 8 earlier versions
-
Dec 2021 — May 2024 [monthly]
Completed NA
-
Jan 2021 — Dec 2021 [monthly]
Completed NA
-
Nov 2020 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Nov 2020 [monthly]
Completed NA
-
May 2018 — Jun 2018 [monthly]
Completed NA
-
Aug 2017 — May 2018 [monthly]
Completed NA
-
May 2017 — Aug 2017 [monthly]
Completed NA
Phase: PHASE4 → NA
-
Jan 2017 — May 2017 [monthly]
Completed PHASE4
First recorded
Nov 2000
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic Cardiac Rhythm and Heart Failure
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.